Epilepsy - Causes and Genetics

Understanding the Causes of Epilepsy Epilepsy is a neurological disorder characterized by a predisposition to recurrent seizures. However, epilepsy is not a single disease—it can result from many different underlying causes. Understanding these causes is essential for diagnosis, treatment, and prognosis. Medical professionals classify epilepsy causes into several broad categories: structural, genetic, infectious, immune, metabolic, and unknown causes. Importantly, in roughly half of all epilepsy cases, no identifiable cause is found despite thorough investigation. Structural Causes: Brain Abnormalities That Trigger Seizures Structural causes involve anatomical brain abnormalities that increase the risk of seizure development. These can be either acquired (developing after birth) or congenital/developmental (present from birth or early development). Acquired Structural Causes Traumatic Brain Injury is one of the most common structural causes. Traumatic brain injury (TBI) accounts for 6% to 20% of epilepsy cases, and the risk increases significantly with injury severity. Even a single moderate-to-severe head injury can cause lasting changes to brain tissue that lower the seizure threshold. Stroke is another major acquired cause, leading to epilepsy in approximately 6% to 10% of stroke survivors. The risk is particularly elevated after severe cortical strokes or intracerebral hemorrhage (bleeding within the brain). Brain Tumors are implicated in about 4% of epilepsy cases. Notably, seizures occur in roughly 30% of individuals with intracranial neoplasms (brain tumors), making seizures a common presenting symptom of brain cancer. Central Nervous System Infections can cause lasting brain damage that increases seizure susceptibility. Brain abscesses or severe infections leave scarring and tissue changes that predispose to future seizures. Congenital and Developmental Structural Causes Mesial Temporal Sclerosis (also called hippocampal sclerosis) is a particularly common cause of temporal lobe epilepsy, one of the most frequent types of epilepsy in adults. This condition involves scarring and neuronal loss in the hippocampus and surrounding temporal lobe structures. Focal Cortical Dysplasia describes regions where the brain's cortex fails to develop normally. These areas of abnormal cortical organization create focal points of abnormal electrical activity. Congenital Brain Malformations such as lissencephaly (smooth brain lacking normal convolutions) or polymicrogyria (abnormally numerous and small brain convolutions) can cause epilepsy from infancy or early childhood. Identifying Structural Causes The critical point about structural causes is that they must be identified through imaging and must be epileptogenic (capable of causing seizures) to be considered true causative factors. Magnetic resonance imaging (MRI) is the gold standard for detecting these structural abnormalities. A structural lesion alone is not sufficient diagnosis—clinicians must establish a clear relationship between the observed abnormality and the patient's seizure pattern. Genetic Causes: Inherited Susceptibility to Seizures Genetic epilepsy results from inherited or newly acquired (de novo) gene variants that increase a person's susceptibility to seizures. It's important to understand that genetic epilepsy is fundamentally different from structural epilepsy: the predisposition to seizures is encoded in the genes, not caused by physical brain damage. The Genetic Landscape Single-gene defects account for only 1% to 2% of epilepsy cases. Most cases involve multiple genes interacting with environmental factors—this complex inheritance pattern makes genetic epilepsy more difficult to predict and explain than simple Mendelian inheritance. How Genes Increase Seizure Risk Many epilepsy genes affect proteins that directly control neuronal excitability: Ion channels (especially sodium and potassium channels) that regulate electrical activity in neurons Neurotransmitter receptors that receive signals from other neurons Signaling proteins that modulate neuronal responses When these genes are mutated, neurons become either abnormally excitable or fail to inhibit activity appropriately, creating conditions favorable for seizure generation. Phakomatoses: Genetic Syndromes with High Epilepsy Risk Phakomatoses are hereditary syndromes characterized by multiple benign tumors throughout the body and nervous system. Two important examples: Tuberous sclerosis complex (TSC): A genetic disorder causing benign tumors in the brain, kidneys, heart, and skin. Seizures occur in 80-90% of TSC patients. Sturge-Weber syndrome: A condition characterized by abnormal blood vessels (port-wine stains) in the face and brain, with high seizure risk due to these vascular abnormalities. Genetic Factors in Early-Onset Epilepsy Certain genes are particularly important in infants and young children who develop seizures very early in life. Understanding these genes is crucial because they may guide targeted treatment approaches. Sodium Channel Genes: SCN3A Variations in the SCN3A gene, which encodes a sodium channel protein, are associated with some of the earliest-onset epilepsies. Interestingly, SCN3A mutations often occur alongside cortical malformations, suggesting that the genetic change affects both normal neuronal electrical function and proper brain development. Sodium-Potassium ATPase Genes: ATP1A3 Mutations in the ATP1A3 gene have been linked to early-onset epilepsies. This gene codes for a critical pump protein (sodium-potassium adenosine triphosphatase) that maintains ion gradients across neuronal membranes. When this pump is disrupted, ion gradients become abnormal, increasing neuronal excitability and seizure risk. Early disruption of ATP1A3 during brain development may contribute directly to abnormal brain development and epileptogenesis (the process by which the brain becomes predisposed to seizures). Associated Brain Abnormalities Imaging studies of patients with these genetic variants often reveal focal cortical dysplasia or lissencephaly, underscoring the complex relationship between genetic mutations, brain development, and seizure susceptibility. Infectious Causes: CNS Infections and Lasting Seizure Risk Central nervous system infections represent a preventable cause of epilepsy in many regions. Infections damage brain tissue and can cause lasting changes that increase seizure susceptibility. High-Risk Infections Herpes Simplex Encephalitis carries a particularly high risk of subsequent epilepsy. Even after successful treatment of the acute infection, survivors frequently develop chronic seizure disorders due to permanent brain damage. Neurocysticercosis (infection with pork tapeworm larvae in the brain) is a major preventable cause of epilepsy in endemic regions—areas where the tapeworm is common due to poor sanitation and handling of pork. This is an important cause of epilepsy worldwide, particularly in Latin America, Africa, and Asia. Other infectious contributors include cerebral malaria (severe malaria with brain involvement), toxoplasmosis (especially in immunocompromised individuals), and toxocariasis (roundworm infection). The key concept is that infections cause epilepsy through tissue damage and inflammation, not through active ongoing infection. Even after the infection is cured, the scarred or damaged brain tissue remains prone to seizures. Immune Causes: Antibody-Mediated Brain Dysfunction Autoimmune encephalitis occurs when the immune system produces antibodies that attack brain tissue. Seizures are a common presentation of autoimmune encephalitis. This category is distinct from infectious encephalitis because the seizures result from immune dysfunction rather than direct infection. Identifying autoimmune causes is important because they may respond to immunotherapy (treatment that suppresses the inappropriate immune response). Metabolic Causes: Genetic and Acquired Disturbances Metabolic causes of epilepsy fall into two important categories that are often confused: Congenital Metabolic Causes Inborn errors of metabolism are genetic disorders affecting metabolism (the chemical processes that sustain life). Examples include: Mitochondrial diseases: Affect the mitochondria (cellular energy factories), limiting energy production in neurons Urea cycle disorders: Impair the metabolism of nitrogen-containing compounds, leading to toxic ammonia accumulation Glucose transporter type 1 deficiency (GLUT1): Prevents adequate glucose entry into the brain, depriving neurons of energy These are true epilepsy causes because they represent a lasting predisposition to seizures due to abnormal metabolism. Acquired Metabolic Disturbances In contrast, acquired metabolic disturbances such as hypoglycemia (low blood sugar), hyponatremia (low sodium), or hypocalcemia (low calcium) can provoke seizures acutely. However, these are considered acute symptomatic seizures, not epilepsy. The distinction is crucial: once the metabolic abnormality is corrected, seizures typically stop. This is fundamentally different from true epilepsy, where the brain retains a lasting predisposition to seizures even after any acute insult is resolved. Unknown Causes: The Largest Category Despite thorough clinical evaluation including imaging, genetic testing, laboratory studies, and electroencephalography (EEG), approximately 50% of epilepsy cases remain idiopathic (without an identifiable cause). This high proportion reflects both the complexity of epilepsy and the limitations of current diagnostic techniques. Even without identifying a specific cause, patients still require treatment, and management focuses on seizure control rather than addressing an underlying cause. <extrainfo> Emerging Molecular Insights and Personalized Approaches Research continues to identify new epilepsy genes and to understand how specific mutations contribute to seizure development. Identification of mutations in epilepsy-related genes may guide personalized treatment selection in the future. Additionally, researchers are investigating biomarkers—measurable biological indicators that could predict which individuals will develop epilepsy after an initial brain insult (such as head injury or stroke). If such biomarkers are validated, they could enable early intervention to prevent epilepsy development before it occurs. </extrainfo>